Cancer Conference | Cancer Congress | Diagnostics Conference | Barcelona | Spain

Theme: Explore the Recent Innovative Treatment & Diagnostic of Oncology

World Cancer 2022

Scientific program

Renowned Speakers

Maude Hebert
University of Quebec in Trois-Rivieres
Canada

Maria Bourazani
Agios Savvas - Anticancer Hospital
Greece

Marco Bernini
Careggi University Hospital, Florence
Italy

Antonio Carlos Wolff
The Johns Hopkins University
USA

Linda A. deGraffenried
The University of Texas at Austin
USA

Guan Chen
Medical College of Wisconsin
USA

Kim Jaffee
Wayne State University
USA

Ragheed Al-Mufti
The West of London Breast Cancer Network
UK

Michael Retsky
Professor at university college London
UK

World Cancer 2022

Publish your full-length article and get free conference passes in 799 Euro

Conference Series LLC Ltd welcomes our esteemed speakers and delegates from all around the world to the ''22^nd World Congress on Cancer and Diagnostics'' which is going to be endured on April 25-26, 2022 | Barcelona, Spain. All the participants and attendees are warmly invited from academia, clinics, private and government-sponsored laboratories, and industries from across the world. Innumerable keynote and scientific presentations, as well as a poster exhibition, are bid to present their work during this two days conference will highlight some of the exciting developments in the fields of cancer biology, cancer etiology, cancer screening and diagnosis, cancer imaging technologies, and cancer treatment. The conference will administer attendees with a chance to create and renew friendships, network, and collaborate on future endeavors and research projects. Hopefully, the activity of this conference will contribute to making a cancer-free world someday.

Cancer is a disease, which involves the abnormal growth of cells that result in the formation of a tumor for which different types of cancer therapies are used for the treatment. However benign tumors are not cancers. The aberrant tumor cells have the propensity of transmission to other local tissues and may also transmit to diverse parts of the body through the blood and the lymphatic system.

The 22^nd World Congress on Cancer and Diagnostics welcomes all the participants from all over the world to attend the grand conference on April 25-26, 2022 in Barcelona, Spain. Which embody brief keynote introductions, narrated talks, brief introductions and presentations, Teachers, Researchers around the world will showboat their research work and will highlight the way wherein Men, Women, and Children of all socioeconomics can be restored on types of cancer and their treatment and prevention.

As the topic describes it all, it is one of the most known diseases all over the world; still, people are not much aware of it. Through this conference, we serve as a platform to all the renowned researchers, scientists, and doctors, scholars to bring their ideas and knowledge on different types of cancer, cancer biomarkers, and types of cancer therapies, blood cancer, breast cancer, gastrointestinal cancer, prostate cancer, ovarian cancer, oral cancer, lung cancer, colorectal, are among them, chemotherapy, targeted therapy, immunotherapy, hormonal therapy are the most common ones. As we realize that these are the name rundown just, there are a few different cancers which will be likely explanations of more passing, if not taken consideration at a beginning period.

Cancer is the second leading cause of death globally. It’s vital to commemorate that cancer is not a one disease – it’s more than 200 cancer diseases involved. Treatments that work for one cancer that doesn’t work for other, it depends upon the several factors that what kind of therapy is needed. And only a global search for answers will guide us get to grasps with this disease. The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer/oncology.

World Cancer 2022 will also explore the unique ideas and approach on worldwide scale and the topics Cancer Biology & Genetics, Organ-Defined Cancers, Oncology: Sub-Specialties, Radiation ,Oncology, Surgical Oncology, Cancer & Stem Cell Therapy, Precision Cancer Medicine & Oncology, Cancer Biomarkers, Cancer Epidemiology, Cancer Prevention & Research, Cancer Therapy & Treatments, Cancer Pharmacology, Cancer Vaccines, Cancer Immunology & Immunotherapy, Oncology Nursing and Care, Complementary & Alternative Methods and Cancer, Cancer Awareness and Survival, Cancer: Lifestyle and Nutrition, Cancer: Psychological & Social Aspects. The global cancer therapy market is estimated to grow with a CAGR of 8.37% during the forecasted period. Certain factors that are driving the market growth include increasing Patient Assistance Programs (PAPs), increasing government initiatives for cancer awareness, rising prevalence of cancer worldwide, and strong R&D initiatives from key players. Oncology Market size was valued at $136.7 billion in 2019 and is poised to grow at a CAGR of 11.9% during the forecast period 2020-2025.

The target therapy segment is expected to show the highest CAGR of 9.68% during the forecast period. The target therapy includes hormone therapies, gene expression modulators, apoptosis inducers, angiogenesis inhibitors, immunotherapies, signal transduction inhibitors, and toxin delivery molecules. . The breast cancer segment is believed to account for the largest market size over the forecast period. As per estimates provided by the Breast Cancer Organization in 2018, it is estimated that over 2,66,120 new cases of invasive breast cancer are expected to be diagnosed in women in the United States, along with 63,960 new cases of non-invasive (in situ) breast cancer. North America currently dominates the market for cancer therapy and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the increased adoption of cancer therapy According to the National Cancer Institute (NCI), in 2016, 1.6 million people suffered from cancer, and around 0.5 million people died from cancer. This figure indicates that the prevalence of cancer is rapidly increasing in the United States. The immunotherapy segment is expected to show fastest growth during the forecast period, registering a CAGR of 10.4%.

The Global Cancer Biomarkers Market is expected to exceed more than US$ 25.50 Billion by 2024 at a CAGR of 12% in the given forecast period. The global top 10 cancer drugs sales was valued at $63,619 million in 2018 and is expected to reach $129,948 million by 2026, registering a CAGR of 9.8% from 2019 to 2026. Furthermore, rise in cancer awareness, increase in R&D activities, and availability of cancer drugs are expected to boost the market growth.

List of some top companies that played a vital role:

AbbVie Inc.
Astellas Pharma Inc.
AstraZeneca PLC
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Johnson & Johnson (Janssen Global Services, LLC,)
Merck & Co., Inc.
Novartis AG
Pfizer Inc.

The global cancer diagnostics market is segmented based on technology, application, and region .Based on region, the market is divided into North America, Europe, Asia, and Rest of the World. Rest of the World comprises Latin America, Pacific countries, and Middle East and Africa.

Session 1- Cancer

Cancer is a disease which has a capacity to differentiate rapidly and give rise to less specialized cells. Cancer cells may be capacity to alter normal cells. Cancer is a genetic disease caused by alteration in genes or DNA. Tumor cells can use the immune system to stay alive and grow. Tumor cells can keep immune from killing. Cancer Cells are malignant; they can spread into nearby tissues. When Cancerous cells spread from one place to another body part called metastatic cancer. There are many types of cancer which named for the tissues or organs or cells where the cancer usually formed.

· Matastatic Cancer

· Local & Malignant Cancer

· Solid and Hematological tumor

· Cancer Grading

· Adrenocortical Cancer

· Chondrosarcoma

Recommended Conferences:

Session 2: Types of cancer

Most of the tumors aren't cancerous. The cancerous tumors are referred to as malignant tumors. In general, medicine implies the study of malignant tumors or cancer. The doctor WHO practices medicine is A medical specialist. There are completely different styles of oncologists. People who specialize in surgery are referred to as surgical oncologists. People who specialize in actinotherapy are referred to as radiation oncologists. People who specialize in the care of persons with cancer and administer therapy are medical oncologists.

· Gastrointestinal Cancers

· Liver Cancer

· Lung Cancer

· Blood Cancer

· Breast cancer

· Prostate cancer

· Ovarian cancer

· Oral cancer

· Bone and musculoskeletal cancer

· Neuro-cancer

· Pediatric cancer

· Head and neck cancer

· Pain and palliative cancer

Recommended Conferences:

Session 3- Etiology and Prevention

“Prevention is better than cure.” – By Johann Wolfgang von Goethe.

It is extremely hard to understand why one people develop cancerous cells and another doesn’t. But some research and analysis showed that certain risk factors which may increase the chances of cancer. Some of the common risk factors can be avoided such as lifestyle and environmental factors. Most of the researches have shown that the majority of cancers are caused by poor lifestyle like unhealthy diet, smoking and obesity. Not all cancers are preventable but we can slow down the risk of cancer by applying healthy habits, such as exercise regularly, quit smoking, limited alcohol intake etc.

· Causes of Cancer

· Etiology For Specific type

· Primary Prevention

· Secondary Prevention

· Lifestyle changes

· Diet & Cancer

· Vaccinations

· Natural Therapy

· Psychological

· Social Aspects

Recommended Conferences:

Session 4- Stages of Cancer

There are four different Stages of Cancer, which include Stage 0 – when no cancer, but some abnormal cells that may give rise to cancerous cells, Stage 1 – When Cancer is located in small area, Stage 2 & 3- When Cancerous cell has spread to larger area including tissues and lymph nodes, and Stage 4 When Cancerous cell has spread to many parts of the body.

· Primary Tumor

· Regional Lymph Nodes

· Distant Metastasis

· Reoccurrence of Cancer

Recommended Conferences:

Session 5- Cancer Diagnostic Techniques

Diagnostic testing involves tests and procedures to verify the presence of malady and determine the right tumor sort, location, extent and stage. We have a tendency to use refined diagnostic technology to pinpoint and judge tumors, and develop a customized treatment arrange. Most of the cancer can be cured if it detect at earlier stage. There are many approaches to cancer diagnose and treatment cancer that will depend on the type of cancer and stage. Cancer diagnose approaches can be more than one. You can determine diagnosis what best is for depend on your own risk.

· Cancer diagnosis

· A review of health history

· Physical examination

· Laboratory tests Biopsy

· Imaging tests

· Nuclear medicine scans

· Endoscopy

Recommended Conferences:

Session 6: Therapies involve in Cancer Treatment

Cancer is the major causes of death in the world. The main aim of cancer treatment is to kill or destroy cancerous cells. Cancer is treated in many ways in which, counting on every person's medical condition and sort of cancer. Common treatments involve therapy. Different treatments embrace surgery and biological therapies.

· Radiation therapy

· Immunotherapy

· Chemotherapy

· Hormone therapy

· Blood and bone marrow transplant

· Biologic therapy

Recommended Conferences:

Session 7- Cancer Screening and Diagnostics

Cancer screening tests goal to seek out cancer early, before it causes symptoms and once it should be easier to treat with success. Effective screening tests square measure those that:

1. Scale back the prospect that somebody World Health Organization screened often can die from the cancer.

2. Have additional potential advantages than harms. (Possible harms of screening tests include hemorrhage or alternative physical harm, inaccurate take a look at results, and over diagnosis—the designation of cancers that will not have caused issues and failed to want treatment.)

3. Diagnosis of cancer at its earliest stages typically provides the most effective likelihood for a cure.

Recommended Conferences:

Session 8- Endocrine and Neuroendocrine Cancer

The nervous system is common regulatory system in the human body. It is usually connected to the brain and the spinal cord through various nerves. Neuroendocrine cancers are type of cancer which rises in specialized cells. These types of cancer are rare but can occur anywhere in the body. Some cancerous cells grow rapidly and some grow slowly in the body. Most common neuroendocrine cancer occurs in lungs, pancreas, appendix, intestines and rectum. Neuroendocrine cancer may be occurs in thymus, thyroid gland, pituitary gland and adrenal gland. Neuroendocrine cancer can be classified by site of formation.

· Origin of NETs

· Classification of NETs

· Primary Tumor Localizations

· NEN Diagnosis

· Hormonal Syndrome in NET

· Pathogenesis of Carcinoid

· Somatostatin Receptors

· Biomarkers, NET- Test

· SSA- resistant Carcinoid Syndrome

· Chemotherapy is not effective in NETs

· Temozolomide in Pancreatic Neuroendocrine Carcinoma

Recommended Conferences:

Session 9: Oncology Biomarkers

The future of cancer management is anticipated to be deeply dependent upon the employment of biomarkers which will guide physicians at each step of malady management. Cancer biomarkers may be used for the correct analysis and management of the malady in several stages. They’ll be helpful for predicting many outcomes throughout the course of malady as well as early detection, outcome prediction and detection of malady return. Cancer biomarkers are sometimes biological molecules found in blood, alternative body fluids, or tissues that have been a proof of a standard or abnormal method, or of a condition or diseases.

· Genetic biomarkers

· Pathological biomarkers

· In silico biomarkers

· Imaging biomarkers

· Glycoprotein biomarkers

Recommended Conferences:

Session 10- Cancer Surgery

A diagnostic assay/surgery/biopsy is that the removal of tissue from any a part of the body to look at it for sickness. Some could take away a little tissue sample with a needle whereas others could surgically take away a suspicious nodule or lump. a diagnostic {test diagnostic assay} could also be performed with the assistance of Associate in Nursing imaging test, like Associate in Nursing ultrasound, CT scan, or imaging.

· Cancer imaging test

· CT-scan test

· Tissue sample examination

· Biopsy for cancer

Recommended Conferences:

Session 11- Cancer Immunology and Immunotherapy

Cancer Immunology is the branch of biology in which explore the interaction between the role of immune system or responses and progression and development of cancer. Immunotherapy or biological therapy is the treatment of cancer in which doctors boosts the natural defenses to fight cancer. There are the three classes of immunotherapy: Immune checkpoint blockade, cellular (t-cell) transfer therapy, Monoclonal antibody and vaccination. Immunotherapy causes side effects which include pain, redness and itchiness etc.

· Cancer Specific Antigens

· Tumour Immunogenicity

· Antitumor Immune Response

· Tumour Elimination

· Cancer Immuno surveillance

· Chemotherapy

· Cancer & Viruses

· Totipotency, pluripotency and multipotency

· Monoclonal Antibody

· Immunodiagnostics

· Immuno-editing

· Future Developments in Cancer Immunology.

Recommended Conferences:

Session 12- Cancer Drug Development

Drug Development is the lengthy procedure because it has ability new drug must be identified and assessed in preclinical and clinical trials. Drug development medication can happen some different ways. If scientist identify new drug by examine numerous compounds in a laboratory procedure for effective ways, like killing or destroying cancerous cells. Cancer drug development is to target DNA or protein. Currently researchers are looking for whole new set of targets. Development of anti-cancer drug is evolving a step towards the invention of novel therapeutics.

Current concept of understanding the kind of cancer invent to conceptual drug design, in which new substance is developed to target a specific disease procedure. At a time, factual medication are found to be having an effectual effect against a various type of cancerous cells. New discovery lead to alteration in designs how medication reach cancerous cells present among the body, thus leading to the capacity to develop a substance. At starting procedure is referred to target and lead identification, validation, and optimization.

· Tumour Targeting Strategies

· Hormonal & Biological Agents

· Cancer Drug Targets

· Clinical Trials

· Anticancer Therapeutics

· Preclinical Models for Drug Evaluation

· Research and Analytical Methods

· Anti-cancer drugs, Pharmacokinetics

Recommended Conferences:

Session 13- Artificial Intelligence and Oncology

Artificial Intelligence means human like intelligence performed by a computer, robot, or other machine. There is various kind of application and uses of artificial intelligence in the field of medical oncology and basic cancer research like in diagnosis, screening, imaging, drug discovering, clinical trials, pain management and treatments etc. Recently technological uses and application of artificial intelligence in oncology are endless. Artificial Intelligence in Oncology covers a huge range of application in cancer management. A new artificial intelligence (AI) system created that not only matches tumors to the best drug combinations, but does so in a way that makes sense to humans. Artificial Intelligence is expecting the best approach to cancer treatment.

· Machine Learning

· Artificial Neural Networks and Deep Learning

· AI and Cancer Imaging

· AI and Clinical Outcomes

· AI and Translational Oncology

· AI and Clinical Decision Making

· AI Limitations and Future Directions.

Recommended Conferences:

Session 14- Cancer Genomics

Genomics is the study of genomes. It is a field of biology which involve the structure, mapping, evolution, and editing of genomes. The genome is the whole set of DNA, which include its genes. The study of cancerous genomes has disclosed the abnormalities in DNA or genes that leads to development and growth in various ways. The invention of cancerous causing genetic and epigenetics alteration in tumor has enabled the development of therapies which target there alteration as well as treatment and diagnosis test which identifies patients who may effective from these therapies.

· ctDNA test methods

· Personalised medicine for cancer

· Adverse Drug Reaction

Recommended Conferences:

Session 15- Cancer Syndrome

Cancer syndromes is the genetic disorder in which hereditary genetic alteration in single or multiple genes predispose the affected of single to the development of tumor. Cancerous syndromes display a high risk of tumor. Hereditary genetic alteration play important role in approximately 5% to 10% of all tumors. These epigenetic alterations happen at different levels, which involve decreased mass degrees of the center histones, adjusted examples of histones post-translational changes and DNA methylation, supplanting of authoritative histone along with histone changes and modification non-coding RNA articulation, in the process of organismal maturing and replicative senescence.

· Paraneoplastic syndromes

· Lungs cancer Syndrome

· Colon Cancer Syndromes

· Bladder cancer Syndromes

· Thyroid Cancer syndromes

Recommended Conferences:

Session 16- Computational Data mining in Cancer

Computational data mining has an ability to understand the difficulties of cancerous-related data has been caused by the application of computer and data sciences, which involve data mining, analytics, machine learning and benefits in imaging technology and probe creation. Computational modeling and simulation are orderly and cheaper tools which able to identify important temporal patterns, characteristic distinct molecular character of tumor states and other related aspects, which include tumor identification and heterogeneity, progression and metastasis, and medication resistance..

Recommended Conferences:

Session 17- Tissue Regeneration And Cancer

Tissue Regenerative medication is the model of renewal and restoration of damaged or destroyed tissues. As the segment for organ development and tissue restoration, stem cells have different and vast-ranging ability, thus describing their ability application and uses to tissue regenerative medication. The identification that compatible model of molecular procedure drive organ development and after birth tissue regeneration has remarkable implications for a different of cytological diseases beyond renewal biology. The examination analysis that organ-specific stem cells acquire all of the changed cells within a given tissue has led to the acceptance of a stem cell inheritance pattern for tissue development, maintenance, and repair. Extending the tissue stem cell hierarchical model to tissue tumorigenesis may transform the pattern in which we form a concept of cancer medication. A basic understanding of stem cell biology is dominant to stay knowledgeable of this mixing technology and the go along with discovery in this with field the ability in clinical application and uses.

· Neural Stem Cells And Regeneration

· Blood Stem Cells And Regeneration

· Muscle Stem Cells And Regeneration

· Stem Cells In Endocrinology

· Liver Stem Cells And Regeneration

· Early Embryonic Development

Recommended Conferences:

Session 18- Vaccines and Biomarkers

Vaccines are medication which helps our body to fight against disease. Vaccine can train are immune system to search and damage or destroy harmful micro-organisms, germs, and cells. There are various kind of vaccines that we receive throughout our life to prevent common sickness or illness. There are also vaccines available for tumor or cancer. There are vaccines which prevent tumor and treatment of cancer. There are vaccinations which prevent people from getting particular cancers caused by viruses. This type of vaccine will only work if a person gets the vaccination before they are infected with the virus.

Research into the molecular biology of hepatocarcinogenesis has known some biomarkers, which could offer additional evidence in order to better comprehend the biology of HCC. An abundance of biomarkers have been shown to have possible analytical implication and a wide variety of molecular markers have been verified to be excellent diagnostic tools for HCC yet it is hard to expose HCC with a single biomarker. Then, marks of a mix of biomarkers might be more imperative for the finding, arranging and visualization of HCC.

· Hepato- Cacinogenesis

· Vaccination

· Biomarkers

· RAPD, Transcriptomic Biomarkers

· Proteomic Biomarkers

· RFLP.

Recommended Conferences:

Session 19- Coronavirus and Cancer

Coronaviruses are the large group of viruses. SARS-CoV- 2 is a novel which caused a pandemic of disease named COVID-19, anyone who expose to infection and developing COVID-19. Recently, it not known that history of cancer patient increases the risk for some sickness or illness from COVID-19. Cancer and its treatment can weaken immune system and reduce your potential to against fight infections. The immune system protects our body against illness and infection caused by viruses like COVID-19.

Recommended Conferences:

Session 20- Cancer Nanotechnology

Cancer nanotechnology is the application and uses of Nano meter product towards the identification, diagnosis, and treatment of cancer. The unique properties of nanomaterial and the connection with cells in and around the tumor micro-environment are enabling new aspects in cancer biology and therapy. The huge of applications of nanotechnology towards cancer continues to expand with exciting new developments in combination treatments, cancer immunotherapy, molecular detection, and imaging.

Scientist will provide a unique forum where scientists at every stage of their career can share unpublished, cancer discovery made possible by the use of nano particles or nano-materials. This meeting will particularly focus on two ends of the spectrum in cancer research: deepening our fundamental understanding of the interactions of nano -materials with tumors and the laboratory favourable environment, and translation of cancer nanotechnology out of the lab and into the clinic. The event will bring together a lively group of exceptional scientists in order to(i) share cutting-edge discovery in cancer nanotechnology by expertise representing the wide range of biological sciences, engineering, and medication (ii) Discussion, presenting of ideas, and promote collaborations, (iii) Enhance growth of fresh researcher during promoting variety.

· Nanoparticle packages

· Energy absorption and radiation

· Laser ablation

· Active pharmaceutical ingredients

· Passive Tumour Accumulation

· Active Tumour Targeting

Recommended Conferences:

Session 21- Cancer Genetics

Genetics is the field of biology that looks at how character passed down from parents to their children through genes. Alteration in genes called mutation, which play an important role in the building blocks of tumor. Alteration in gene can cause a cell to make proteins that affect cell growth and division into new cells. This type of alteration in genes leads to out of control cells, which can cause cancer.

· Oncogenes

· Proto-oncogenes

· Cancer predisposition

· Tumour Suppressors

· Genetic Cancer Syndromes

· Genetic Counselling & Testing

Recommended Conferences:

Session 22 – Cancer Misconception And Myth

It’s important to range the awareness about cancer and crucial to stay away from myth and misconceptions. The internet full of myths and misconceptions related to cancer which stop patient from getting diagnosed on time and availing treatments.

This event tries to present cancer myths and misconceptions vs facts to make you aware of this disease.

· Cancer is always fatal

· Cancer is contagious

· Radiation therapy will kill you

· Cancer surgery for cancer will cause cancer to spread

· All lumps are cancerous

· Your attitude determines the outcome of cancer treatment.

Recommended Conferences:

Session 23– Current Application and Future of cancer

The main agenda is to focus on new translational advances in the treatment of cancer as well as provide updates of predictable therapies for the number of the most common tumor types. The major emphasis will be clinical features of cancer treatment in this century with debate of important scientific advances underlying the novel methods still in preclinical development.

· Artificial intelligence and oncology

· machine learning and oncology

· Deep Learning and Cancer research

· Decision Management, Perception

· Robotic Process Automation

· Cancer research.

Recommended Conferences:

Session 24– Cancer Nursing

Cancer patient Nurse is a professional who take cares of Cancer patients. Cancer patient nursing care could be defined as the expert care and completing the needs of patients during the time of their disease, while may involve some screening methods and preventive measures that should be taken care of patient care, fatigue, infection etc.

· Nursing Assessment

· Nursing Intervention

· Nursing Education

· Nursing Management

· Nursing Law

· Clinical Nursing

· Critical Care

· Continuing Nursing Education

Recommended Conferences:

Session 25- Recent Research and Innovations in Oncology

Continuous malignant tumor drug discovery and development is vital to seek out an entire cure for cancer. Because of the drug resistance developed by tumor cells for existing treatments, this is often changing into a compulsory approach to fight the illness.

• Scientific investigations on inhibitors of stop CHK1 will be another milestone for antineoplastic drug discovery approach.

• Cancer cells are specifically dependent on molecular chaperones and related proteins that regulate homeostasis. These are promising targets for new anticancer therapies.

• Deregulated necrobiosis is hallmark of cancer and Bcl-2 family of proteins are crucial to mediating the pathway of this method. Inhibiting their method may be a big approach for developing new malignant tumor medication. Several plant sources are noted to be valuable sources of novel anti-cancer properties.

Recommended Conferences:

Session 26- Oncology Saviours

Malignant growth is to a point sort of common sickness. For the foremost half, this category should incorporate simply people United Nations agency are noticeable for being created due by malignant growth, especially, the people United Nations agency have promptly taken associate degree interest in the open policy of problems associated with sickness. As we want to take individuals' eudemonia. Information regarding individuals' eudemonia, as well as their state of affairs as a malignancy survivor, ought to faithfully be featured by high caliber, non-independently printed solid supply. By perceptive category people causes malignancy,United Nations agency has terminated from cancer growth or its treatment for people.

· Breast Cancer Saviour

· Colorectal Cancer Saviour

· Kidney Cancer Saviour

· Liver Cancer Saviour

· Lung Cancer Saviour

· Pediatrics Cancer Saviour

· Testicular Cancer Saviour

Recommended Conferences:

Session 27- Psycho-Oncology

The psychological, social, behavioural and moral aspects of cancer. Psychooncology focuses on the two great psychological dimensions of cancer- (1) patients' psychological responses to cancer at all stages of the disease, as well as their families and caregivers; and (2) the psychological, behavioral and social factors that may influence the disease process.The dimensions of psycho-oncology have changed as more children and adults have earned the title of cancer survivor. The impact of cancer is far greater than the millions of new cancer cases worldwide each year. Many cancer patients remain out of sight of the health services due to societal stigma and lack of resources to diagnose, treat and support.

Recommended Conferences:

Session 28- Clinical Oncology

Clinical oncology relates to form of cancer treatment that’s not involving surgery, including radiotherapy and systemic therapies. Clinical oncologists are involved within the management of every type of cancer. They work on large multidisciplinary teams that specialize in the treatment of cancer affecting particular parts of the body or systems. Some patients is cured, except for others the stress is on effective palliative care and improving quality of life.

· Medical Oncology

· Clinical Trials

· Radiology Surgery

· Basic Research

· Epidemiology

· Palliative Care

Recommended Conferences:

Session 29- Surgical Oncology

Surgical Oncology is a field of medicine that uses surgery to treat cancer. Its main goal is to search out harmful tumors in your body and take away them. Surgical oncologists use surgery to boost your condition. Their main job is to get rid of tumors and nearby tissue that has cancer cells in it. They also do procedures called biopsies that tell if you've got cancer and the way severe it's. There are a few different types of surgeries:

· Curative

· Debulking

· Supportive

Recommended Conferences:

Session 30- Neuro-Oncology

Neuro-oncology is the study of cancers within the brain and medulla spinalis Cancers within the nervous system are usually serious and critical. In some cases, survival is extended using chemotherapy and radiation therapy.

· Surgical Neuro-oncology

· Neurosurgical Oncology

· Tumor Biomarkers

· Brain Injury Rehabilitation

· Pathophysiology in Neuro-Oncology

Recommended Conferences:

Session 31- Pediatric Cancer

Pediatric Oncology is rare, and more readily diagnosed and treated than ever. Paediatric oncology is research and cancer treatment for children and young adults. Pediatric oncologists study and train in both pediatrics and oncology. The types of cancers that develop in children are often different from cancers that develop in adults.

Pediatric Cancer is not a single disease type, but an large group of diseases that include blood cancers (leukemia and lymphoma), brain tumors and other solid tumors of the organs, bones or soft tissues.

· Leukemia

· Brain and neural structure tumors

· Neuroblastoma

· Wilms tumor

· Lymphoma

· Bone cancer

Recommended Conferences:

Session -32 Lung Cancer

Lung cancer occurs when cells divide within the lungs violently. This causes tumor to grow. These can reduce a person’s ability to breathe and spread to other parts of the body. Carcinoma is that the third most typical cancer and therefore the main cause cancer-related death within the U.S. it's commonest in males, and within the U.S., Black males are around 15% more likely to develop it than white males.

Recommended Conferences:

Session- 33 Liver Cancer

Liver cancer is cancer that begins within the cells of your liver. Your liver could be a football-sized organ that sits within the upper right portion of your abdomen, beneath your diaphragm and above your stomach.

Several styles of cancer can form within the liver. The foremost common form of liver disease is hepatoma, which begins within the main kind of liver cell (hepatocyte). Other forms of carcinoma, like intrahepatic cholangiocarcinoma and hepatoblastoma, are much less common.

Recommended Conferences:

Session- 34 Blood Cancer

Most blood cancers, also called hematologic cancers, start in the bone marrow, which is where blood is produced. Blood cancers occur when abnormal blood cells start growing out of control, interrupting the function of normal blood cells, which fight off infection and produce new blood cells.

There are three major types of blood cancer:

· Leukemia

· Lymphoma

· Myeloma

Recommended Conferences:

Session-35 Gynaecology Cancer

Gynaecological cancer is a term used for all the types of cancer that can occur in or on a woman's reproductive organs and genitals. This includes cancers of the vulva, vagina, cervix, uterus, fallopian tubes and ovaries.

Recommended Conferences:

Session-36 Prostate Cancer

Prostate cancer begins when cells in the prostate gland start to grow out of control. The prostate is a gland found only in males. It makes some of the fluid that is part of semen.

Recommended Conferences:

Session 37 Cancer Pathophysiology

Cancer has a complex Pathophysiology. Pathologists are physicians who are concerned primarily with the study of disease in all its aspects. This includes cause of the disease, diagnosis, how the disease develops (pathogenesis), mechanism and natural course of the disease. They also deal with biochemical features, progression, and prognosis or outcome of the disease.

Pathology of cancers and other complex disorders have undergone a sea change after development of technologies like immunohistochemistry, flow cytometry, and molecular biologic approaches to cancer diagnosis.

Recommended Conferences:

Major Cancer Associations across the Globe:

American Association for Cancer Research
Virginia Cancer Institute
American Brain Tumor Association
American Society of Pediatric Hematology/Oncology
Association of Cancer Physicians
American Childhood Cancer Organization
American Society of Clinical Oncology
Australasian Lung Cancer Trials Group
International Cancer Research Partnership (ICRP)
American Association for Cancer Research (AACR)
American Society of Clinical Oncology (ASCO)
International Agency for Research on Cancer (IARC)
Cancer Society of New Zealand
Irish Cancer Society
Australian Cervical Cancer Foundation
Medical Centre Cologne
Cancer Research UK
Australian Prostate Cancer Research
Peter McCollum Cancer Centre
The European Cancer Organization (ECCO)
German Cancer Research Centre

Major Medical Universities Worldwide:

Harvard University
University of Minnesota
Mayo Medical School
Pittsburgh School of Medicine
Yale University
University of Cambridge
University of Oxford Stanford University
Yale University
Emory University
John Hopkins University
Kings College London
Feinberg School of Medicine
University of Wisconsin
UNC School of Medicine
Karolinska University
The University of Tokyo
National University of Singapore (NUS)
Kyoto University
University of Hong Kong (HKU)
Peking University
Seoul National University (SNU)
National Taiwan University (NTU)
Osaka University
Tsinghua University0
The Chinese University of Hong Kong (CUHK)
Fudan University
The Hong Kong University of Science and Technology (HKUST)
Taipei Medical University
Mahidol University
KAIST - Korea Advanced Institute of Science and Technology
Yonsei University
Shanghai Jiao Tong University
Nanyang Technological University (NTU)
Chulalongkorn University
Tohoku University
Tokyo Medical and Dental University
Kyushu University
Nagoya University
Hokkaido University
Sungkyunkwan University
University of Science and Technology of China
Pohang University of Science and Technology (POSTECH)
Korea University
Universiti Malaya (UM)
Zhejiang University
Keio University
Indian Institute of Science
University of Tsukuba
University of Delhi

Visa Application Documents

For conference attendance and participation, only Business Visa should be applied. Contact your nearest travel agent/visa information center/ Barcelona, Spain Embassy for the right form.

All visas for visiting / Barcelona, Spain shall be processed by respective authorities only upon submission of proper documents through the correct channel.

In case of non-furnishing of documents, non-adherence to guidelines visas shall be cancelled by respective authorities.

The minimum supportive documents that may be required while applying for / Barcelona, Spain visa include: Letter of invitation,

Abstract acceptance letter (if speaker),

Registration payment receipt,

Accommodation confirmation letter issued under conference letterhead.

For a letter of invitation and accommodation confirmation, payment of registration fees and accommodation charges may be a prerequisite.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	April 25-26, 2022
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View